Tatva Chintan Pharma

769.00
+3.75
(0.49%)
Market Cap
1,798.80 Cr
EPS
13.26
PE Ratio
315.37
Dividend Yield
0.13 %
Industry
Chemicals
52 Week High
1,222.00
52 Week Low
621.00
PB Ratio
2.44
Debt to Equity
0.15
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+60.00 %
+60.00 %
Hold
Hold+20.00 %
+20.00 %
Sell
Sell+20.00 %
+20.00 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,091.20
#1 1,57,233.10
75.05
12,522.60
#1 5.69
#1 1,747
40.49
62.38
2,914.90
86,404.90
69.15
13,221.50
-11.53
1,336
24.61
47.22
3,912.70
42,981.00
94.28
4,387.70
-25.09
435
57.50
53.19
2,110.90
28,791.20
41.64
7,757.90
-3.26
811
-51.46
61.69
461.90
22,803.10
#1 41.05
4,227.40
0.66
411
34.98
57.07
4,242.10
21,029.60
72.94
2,120.90
0.37
271
34.94
43.24
6,787.00
19,982.10
41.26
4,783.90
-13.69
324
#1 121.26
63.18
4,572.60
19,792.80
43.20
#1 13,843.30
-
563
-83.27
56.39
1,778.20
18,433.80
45.52
1,938.80
-8.77
323
18.04
65.74
474.65
17,207.00
52.30
6,380.70
-3.61
417
-27.27
65.89
Forecast
Actual
Growth Rate
Revenue Growth
-6.61 %
Net Income Growth
-33.19 %
Cash Flow Change
252.92 %
ROE
-53.39 %
ROCE
-33.66 %
EBITDA Margin (Avg.)
22.20 %

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
52
62
81
111
109
127
109
99
90
92
122
125
115
97
85
103
107
84
86
109
Expenses
41
54
56
84
81
88
81
77
73
79
103
112
93
76
73
83
93
78
79
99
EBITDA
11
8
25
27
28
39
29
22
17
13
19
14
22
21
12
20
14
6
7
10
Operating Profit %
20 %
11 %
31 %
23 %
24 %
29 %
23 %
22 %
17 %
12 %
15 %
10 %
19 %
21 %
13 %
16 %
12 %
7 %
8 %
8 %
Depreciation
2
2
2
2
2
2
2
2
2
2
2
3
6
7
7
6
7
7
7
7
Interest
1
1
1
1
1
1
1
1
1
1
2
3
3
3
0
0
0
0
0
0
Profit Before Tax
8
6
23
24
24
35
26
19
14
9
14
8
13
11
5
14
7
-1
-0
2
Tax
2
2
2
3
1
3
3
2
4
2
3
-9
4
3
2
4
2
-0
-0
1
Net Profit
7
4
21
21
23
32
23
18
10
7
12
17
10
8
4
10
5
-1
0
1
EPS in ₹
3.34
1.77
10.39
10.51
11.52
15.02
10.29
7.90
4.42
3.21
5.24
7.65
4.29
3.43
1.48
4.11
2.23
-0.29
0.06
0.44

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
144
188
249
315
658
759
819
Fixed Assets
57
67
111
120
160
196
427
Current Assets
77
114
133
184
436
312
298
Capital Work in Progress
10
6
5
10
52
231
77
Investments
1
0
0
0
0
0
10
Other Assets
76
115
133
185
447
332
305
Total Liabilities
144
188
249
315
658
759
819
Current Liabilities
63
73
88
118
171
239
80
Non Current Liabilities
22
35
44
31
14
5
2
Total Equity
59
80
118
166
473
515
737
Reserve & Surplus
51
72
110
146
451
493
714
Share Capital
8
8
8
20
22
22
23

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-10
8
-5
-6
59
-36
8
Investing Activities
-30
-17
-40
-21
-197
-101
-121
Operating Activities
13
7
25
20
20
28
98
Financing Activities
7
17
10
-5
235
38
31

Share Holding

% Holding
Jul 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
75.02 %
72.02 %
72.02 %
72.02 %
72.02 %
72.02 %
72.02 %
72.02 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.41 %
4.21 %
3.65 %
3.37 %
3.33 %
3.36 %
3.30 %
DIIs
5.52 %
7.36 %
7.78 %
7.95 %
10.56 %
11.16 %
11.52 %
11.71 %
11.07 %
13.68 %
13.79 %
13.06 %
12.84 %
10.63 %
6.82 %
6.34 %
5.46 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.89 %
6.44 %
6.62 %
6.35 %
6.03 %
5.49 %
5.01 %
5.09 %
5.91 %
6.23 %
8.72 %
9.38 %
10.49 %
12.44 %
15.95 %
16.33 %
16.92 %
Others
5.42 %
7.03 %
6.43 %
6.53 %
4.24 %
4.19 %
4.31 %
4.03 %
3.85 %
5.07 %
1.06 %
1.33 %
1.00 %
1.54 %
1.87 %
1.95 %
2.30 %
No of Share Holders
11
89,438
88,311
89,930
84,358
76,267
71,958
70,037
70,799
71,340
74,628
74,519
73,730
73,912
79,623
79,009
78,393

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 5 2 2 2 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.22 0.12 0.19 0.3 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 May 2025 761.40 706.00
28 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2025 843.90 814.75
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Oct 2024 1,002.00 949.30
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 1,000.80 972.05
07 Sept 2024 DIVIDEND Dividend
₹ 2.00 /share
06 Sept 2024 1,228.15 972.95
08 Sept 2023 DIVIDEND Dividend
₹ 2.00 /share
08 Sept 2023 1,835.95 1,636.45
09 Sept 2022 DIVIDEND Dividend
₹ 2.00 /share
08 Sept 2022 2,478.80 2,480.20

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance4 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 05, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended On 31 March 2025May 02, 2025
Appointment Of Secretarial Auditor Cost Auditor And Internal AuditorMay 02, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 02, 2025
Corporate Action-Board approves DividendMay 02, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 02.05.2025May 02, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 29, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 25, 2025
Board Meeting Intimation for Board Meeting Intimation For Intimation Of Board Meeting To Be Held On Friday 02.05.2025Apr 25, 2025
Intimation Of Change In Contact Details Of MUFG Intime India Private Limited Registrar And Share Transfer Agent (RTA) Of The Company.Apr 19, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 28, 2025
Integrated Filing (Financial)Jan 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 28.01.2025Jan 28, 2025
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended On 31 December 2024Jan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 28.01.2025Jan 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Intimation For Change Of Name Of Registrar And Share Transfer Agent (RTA) Of The Company.Jan 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 04, 2024
Announcement under Regulation 30 (LODR)-Credit RatingNov 06, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 25, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 25, 2024
Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 25.10.2024Oct 25, 2024
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended 30 September 2024Oct 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 16, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 25.10.2024Oct 16, 2024
Disclosure Of Events / Information Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended. (''SEBI Listing Regulations'')Oct 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 05, 2024
Closure of Trading WindowSep 25, 2024
Clarification On Increase / Spurt In VolumeSep 25, 2024
Clarification sought from Tatva Chintan Pharma Chem LtdSep 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 23, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 21, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 20, 2024

Technical Indicators

RSI(14)
Neutral
59.30
ATR(14)
Less Volatile
35.03
STOCH(9,6)
Neutral
60.45
STOCH RSI(14)
Overbought
81.58
MACD(12,26)
Bullish
3.74
ADX(14)
Weak Trend
19.78
UO(9)
Bearish
45.06
ROC(12)
Uptrend And Accelerating
6.28
WillR(14)
Neutral
-33.56